FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease (Q42976674)

12 November 2017

FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease (English)

1 reference

12 November 2017

6

1 reference

12 November 2017

12

1 reference

12 November 2017

Alper Sonmez

2

0 references

Tayfun Eyileten

7

object named as

Tayfun Eyileten

1 reference

12 November 2017

Mahmut I Yilmaz

1

1 reference

12 November 2017

Mutlu Saglam

3

1 reference

12 November 2017

Halil Yaman

4

1 reference

12 November 2017

Selim Kilic

5

1 reference

12 November 2017

Kayser Caglar

8

1 reference

12 November 2017

Yusuf Oguz

9

1 reference

12 November 2017

Abdulgaffar Vural

10

1 reference

12 November 2017

Mujdat Yenicesu

11

1 reference

12 November 2017

language of work or name

English

0 references

publication date

7 July 2010

1 reference

12 November 2017

1 reference

12 November 2017

78

1 reference

12 November 2017

7

1 reference

12 November 2017

679-685

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2010.194

12 November 2017

0 references

cites work

Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

Forearm reactive hyperemia and mortality in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

Endothelial dysfunction and the kidney: emerging risk factors for renal insufficiency and cardiovascular outcomes in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

Serum visfatin concentration and endothelial dysfunction in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

Hemoglobin is inversely related to flow-mediated dilatation in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

Serum Fetuin-A Concentration and Endothelial Dysfunction in Chronic Kidney Disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

Dietary phosphorus acutely impairs endothelial function

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

Fibroblast growth factor 23 and the future of phosphorus management

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

Fibroblast Growth Factor 23 (FGF23) Predicts Progression of Chronic Kidney Disease: The Mild to Moderate Kidney Disease (MMKD) Study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

Fibroblast growth factor receptor-1 signaling induces osteopontin expression and vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

Calcification and cardiovascular problems in renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

Effect of pravastatin on cardiovascular events in people with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

ADMA, proteinuria, and insulin resistance in non-diabetic stage I chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

Mutation of the mouse klotho gene leads to a syndrome resembling ageing

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

Klotho protein protects against endothelial dysfunction.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

Endothelial dysfunction in the klotho mouse and downregulation of klotho gene expression in various animal models of vascular and metabolic diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

Amelioration of the premature ageing-like features of Fgf-23 knockout mice by genetically restoring the systemic actions of FGF-23

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

U-shaped Dose Response in Vasomotor Tone: A Mixed Result of Heterogenic Response of Multiple Cells to Xenobiotics

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

Production of nitric oxide, but not prostacyclin, is reduced in klotho mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

Local shear stress and brachial artery flow-mediated dilation: the Framingham Heart Study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

Vitamin D levels and patient outcome in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.194

7 January 2021

Identifiers

DOI

10.1038/KI.2010.194

1 reference

12 November 2017

1 reference